I39M (p.Ile39Met) variant of ATL1 (Atlastin-1)
I39M (p.Ile39Met) in ATL1 (Atlastin-1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
I39M (p.Ile39Met) variant details
- p.Ile39Met
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available